ApprovalTrail

Approval · Notice of Compliance 9753 · 2008

IBUPROFEN (TABLETS): Notice of Compliance 9753

Issued September 2, 2008

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
9753
Date
September 2, 2008
Product type
Nonprescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Reason
New manufacturer and product name
Therapeutic class
Non-steroidal anti-inflammatory / analgesic / antipyretic agent
Canadian reference product
MOTRIN (Mcneil Consumer Healthcare)

Products in this notice

BrandDINStatus today
IBUPROFEN (TABLETS)02314754Marketed
IBUPROFEN (TABLETS)02314770Marketed
IBUPROFEN (CAPLETS)02314762Marketed

Medicinal ingredients